BMS 1612 (Baraclude 1 mg)
Generic Name: entecavir
Pill with imprint BMS 1612 is Pink, Three-sided and has been identified as Baraclude 1 mg. It is supplied by Bristol-Myers Squibb.
Baraclude is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Baraclude 1 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BMS 1612
Baraclude
- Generic Name
- entecavir
- Imprint
- BMS 1612
- Strength
- 1 mg
- Color
- Pink
- Size
- 10.00 mm
- Shape
- Three-sided
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
- Inactive Ingredients
-
lactose monohydrate, microcrystalline cellulose, povidone, magnesium stearate, titanium dioxide, hypromelloses, polyethylene glycol 400, ferric oxide red
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00003-1612 | |
| 49884-0105 | Par Pharmaceutical, Inc. |
Related Images for "BMS 1612"
More about Baraclude (entecavir)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 1 Review
- Generic Availability
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
- FDA Alerts (1)
- FDA Approval History
Consumer resources
- Baraclude
- Baraclude (Advanced Reading)
- Baraclude (Entecavir Oral Solution)
- Baraclude (Entecavir Tablets)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
